Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Head and Neck Pathology
Erschienen in: Head and Neck Pathology 1/2017

28.02.2017 | Original Paper

Update From The 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Nasopharynx

verfasst von: Edward B. Stelow, Bruce M. Wenig

Erschienen in: Head and Neck Pathology | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

The current WHO classification system for tumors of the head and neck has made few changes from the previous edition with regards to tumors of the nasopharynx. The classification system is discussed here with particular attention to nasopharyngeal carcinoma, nasopharyngeal papillary adenocarcinoma, salivary gland anlage tumor, hairy polyp, juvenile angiofibroma, and other tumors.
Literatur
1.
2.
Niedobitek G, Hansmann ML, Herbst H, Young LS, Dienemann D, Hartmann CA, Finn T, Pitteroff S, Welt A, Anagnostopoulos I, Friedrich R, Lobeck H, Sam CK, Araujo I, Rickinson AB, Stein H. Epstein–Barr-Virus and Carcinomas—undifferentiated carcinomas but not squamous-cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol. 1991;165:17–24.CrossRefPubMed
3.
Goldsmith DB, West TM, Morton R. HLA associations with nasopharyngeal carcinoma in southern Chinese: a meta-analysis. Clin Otolaryngol. 2002;27:61–7.CrossRefPubMed
4.
5.
Hildesheim A, Chen CJ, Caporaso NE, Cheng YJ, Hoover RN, Hsu MM, Levine PH, Chen IH, Chen JY, Yang CS, Daly AK, Idle JR. Cytochrome P4502e1 genetic polymorphisms and risk of nasopharyngeal carcinoma—results from a case-control study conducted in Taiwan. Cancer Epidemiol Biomar. 1995;4:607–10.
6.
Zou XN, Lu SH, Liu B. Volatile N-nitrosamines and their precursors in Chinese salted fish—a possible etiologic factor for NPC in China. Int J Cancer. 1994;59:155–8.CrossRefPubMed
7.
Ji XM, Zhang WD, Xie CH, Wang BC, Zhang G, Zhou FX. Nasopharyngeal carcinoma risk by histologic type in central China: impact of smoking, alcohol and family history. Int J Cancer. 2011;129:724–32.CrossRefPubMed
8.
Reddy SP, Raslan WF, Gooneratne S, Kathuria S, Marks JE. Prognostic-significance of keratinization in nasopharyngeal carcinoma. Am J Otolaryngol. 1995;16:103–8.CrossRefPubMed
9.
Shanmugaratnam K, Chan SH, Dethe G, Goh JEH, Khor TH, Simons MJ, Tye CY. Histo-pathology of nasopharyngeal carcinoma—correlations with epidemiology, survival rates and other biological characteristics. Cancer 1979;44:1029–44.CrossRefPubMed
10.
Sun XM, Su SF, Chen CY, Han F, Zhao C, Xiao WW, Deng XW, Huang SM, Lin CG, Lu TX. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol. 2014;110:398–403.CrossRefPubMed
11.
Robinson M, Suh YE, Paleri V, Devlin D, Ayaz B, Pertl L, Thavaraj S. Oncogenic human papillomavirus-associated nasopharyngeal carcinoma: an observational study of correlation with ethnicity, histological subtype and outcome in a UK population. Infect Agents Cancer 2013;8:30.CrossRefPubMedPubMedCentral
12.
Wenig BM, Hyams VJ, Heffner DK. Nasopharyngeal papillary adenocarcinoma. a clinicopathologic study of a low-grade carcinoma. Am J Surg Pathol. 1988;12:946–53.CrossRefPubMed
13.
Pineda-Daboin K, Neto A, Ochoa-Perez V, Luna MA. Nasopharyngeal adenocarcinomas: a clinicopathologic study of 44 cases including immunohistochemical features of 18 papillary phenotypes. Ann Diagn Pathol. 2006;10:215–21.CrossRefPubMed
14.
Dehner LP, Valbuena L, Perezatayde A, Reddick RL, Askin FB, Rosai J. Salivary-gland anlage tumor (congenital pleomorphic adenoma)—a clinicopathological, immunohistochemical and ultrastructural-study of 9 cases. Am J Surg Pathol. 1994;18:25–36.CrossRefPubMed
15.
Herrmann BW, Dehner LP, Lieu JEC. Congenital salivary gland anlage tumor: a case series and review of the literature. Int J Pediatr Otorhinolaryngol. 2005;69:149–56.CrossRefPubMed
16.
Heffner DK, Thompson LD, Schall DG, Anderson V. Pharyngeal dermoids (“hairy polyps”) as accessory auricles. Ann Otol Rhinol Laryngol. 1996;105:819–24.CrossRefPubMed
17.
Luk IS, Chan JK, Chow SM, Leung S. Pituitary adenoma presenting as sinonasal tumor: pitfalls in diagnosis. Hum Pathol. 1996;27:605–9.CrossRefPubMed
18.
Byrne MN, Sessions DG. Nasopharyngeal craniopharyngioma. Case report and literature review. Ann Otol Rhinol Laryngol. 1990;99:633–9.CrossRefPubMed
19.
Apostol JV, Frazell EL. Juvenile nasopharyngeal angiofibroma. A clinical study. Cancer. 1965;18:869–78.CrossRefPubMed
20.
Hubbard EM. Nasopharyngeal angiofibromas. AMA Arch Pathol. 1958;65:192–204.PubMed
21.
Neel HB III, Whicker JH, Devine KD, Weiland LH. Juvenile angiofibroma. review of 120 cases. Am J Surg. 1973;126:547–56.CrossRefPubMed
22.
Sternberg SS. Pathology of juvenile nasopharyngeal angiofibroma; a lesion of adolescent males. Cancer. 1954;7:15–28.CrossRefPubMed
23.
Giardiello FM, Hamilton SR, Krush AJ, Offerhaus JA, Booker SV, Petersen GM. Nasopharyngeal angiofibroma in patients with familial adenomatous polyposis. Gastroenterology. 1993;105:1550–2.CrossRefPubMed
24.
Guertl B, Beham A, Zechner R, Stammberger H, Hoefler G. Nasopharyngeal angiofibroma: an APC-gene-associated tumor? Hum Pathol. 2000;31:1411–3.CrossRefPubMed
25.
Chen KT, Bauer FW. Sarcomatous transformation of nasopharyngeal angiofibroma. Cancer. 1982;49:369–71.CrossRefPubMed
26.
Spagnolo DV, Papadimitriou JM, Archer M. Postirradiation malignant fibrous histiocytoma arising in juvenile nasopharyngeal angiofibroma and producing alpha-1-antitrypsin. Histopathology. 1984;8:339–52.CrossRefPubMed
27.
Beham A, Fletcher CD, Kainz J, Schmid C, Humer U. Nasopharyngeal angiofibroma: an immunohistochemical study of 32 cases. Virchows Arch A Pathol Anat Histopathol. 1993;423:281–5.CrossRefPubMed
28.
Hwang HC, Mills SE, Patterson K, Gown AM. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol. 1998;11:1122–6.PubMed
29.
Abraham SC, Montgomery EA, Giardiello FM, Wu TT. Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas. Am J Pathol. 2001;158:1073–8.CrossRefPubMedPubMedCentral
30.
31.
Heffelfinger MJ, Dahlin DC, MacCarty CS, Beabout JW. Chordomas and cartilaginous tumors at the skull base. Cancer. 1973;32:410–20.CrossRefPubMed
32.
Hoch BL, Nielsen GP, Liebsch NJ, Rosenberg AE. Base of skull chordomas in children and adolescents: a clinicopathologic study of 73 cases. Am J Surg Pathol. 2006;30:811–8.CrossRefPubMed
33.
Mitchell A, Scheithauer BW, Unni KK, Forsyth PJ, Wold LE, McGivney DJ. Chordoma and chondroid neoplasms of the spheno-occiput. An immunohistochemical study of 41 cases with prognostic and nosologic implications. Cancer. 1993;72:2943–9.CrossRefPubMed
34.
O’Connell JX, Renard LG, Liebsch NJ, Efird JT, Munzenrider JE, Rosenberg AE. Base of skull chordoma. A correlative study of histologic and clinical features of 62 cases. Cancer. 1994;74:2261–7.CrossRefPubMed
35.
Perzin KH, Pushparaj N. Nonepithelial tumors of the nasal cavity, paranasal sinuses, and nasopharynx. A clinicopathologic study. XIV: Chordomas. Cancer. 1986;57:784–96.CrossRefPubMed
36.
Meis JM, Raymond AK, Evans HL, Charles RE, Giraldo AA. “Dedifferentiated” chordoma. A clinicopathologic and immunohistochemical study of three cases. Am J Surg Pathol. 1987;11:516–25.CrossRefPubMed
37.
Mendenhall WM, Mendenhall CM, Lewis SB, Villaret DB, Mendenhall NP. Skull base chordoma. Head Neck. 2005;27:159–65.CrossRefPubMed
38.
Wojno KJ, Hruban RH, Garin-Chesa P, Huvos AG. Chondroid chordomas and low-grade chondrosarcomas of the craniospinal axis. An immunohistochemical analysis of 17 cases. Am J Surg Pathol. 1992;16:1144–52.CrossRefPubMed
39.
Sangoi AR, Karamchandani J, Lane B, Higgins JP, Rouse RV, Brooks JD, McKenney JK. Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases. Mod Pathol. 2011;24:425–9.CrossRefPubMed
40.
Hanna E, Wanamaker J, Adelstein D, Tubbs R, Lavertu P. Extranodal lymphomas of the head and neck—a 20-year experience. Arch Otolaryngol. 1997;123:1318–23.CrossRef
41.
Jaffe ES. Lymphoid lesions of the head and neck: A model of lymphocyte homing and lymphomagenesis. Modern Pathol. 2002;15:255–63.CrossRef
Metadaten
Titel
Update From The 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Nasopharynx
verfasst von
Edward B. Stelow
Bruce M. Wenig
Publikationsdatum
28.02.2017
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 1/2017
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-017-0787-0

Weitere Artikel der Ausgabe 1/2017

Head and Neck Pathology 1/2017 Zur Ausgabe

Original Paper

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What Is New in the 2017 WHO Blue Book for Tumors and Tumor-Like Lesions of the Neck and Lymph Nodes

Original Paper

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Mucosal Melanomas

Original Paper

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors

Original Paper

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Nasal Cavity, Paranasal Sinuses and Skull Base

Original Paper

Update from the 4th Edition of the World Health Organization of Head and Neck Tumours: Tumours of the Oral Cavity and Mobile Tongue

Original Paper

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Hematolymphoid Tumours

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Zielgerichtete Therapie Leitthema

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …